Skip to content

Efficacy of mako,marznjosh,baboona,qaisoom in vaginal discharge

Efficacy of Unani formulation (Mako, Marzanjosh, Baboona, Qaisoom) in Vaginal Discharge Syndrome: A placebo controlled double blind study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067720
Enrollment
200
Registered
2024-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis

Interventions

Intervention1: Vaginal wash with Hydroalcoholic extract of the test drug Solanum nigrum, Origanum majorana, Achillea fragmantissima, Matricaria chamomila (mako, marzanjosh, qaisoom, baboona): Vaginal

Sponsors

Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married females in the reproductive age group (18 to 49 years) Subjects presenting with white discharge Per vaginum Subjects presenting with chronic cervicitis and erosion

Exclusion criteria

Exclusion criteria: Pregnant females Patient presenting with discharge due to sexually transmitted infections and pelvic inflammatory disease Patient with systemic diseases like Diabetes mellitus Malignancy etc

Design outcomes

Primary

MeasureTime frame
Change in vaginal pHTimepoint: After every 15 days during trial to record vaginal pH drug compliance and any adverse effects. Once post-trial after menstruation

Secondary

MeasureTime frame
Improvement in vulvo vaginal symptoms like discharge Improvement in Quality of life Timepoint: After every 15 days during trial to record vaginal pH drug compliance and any adverse effects. Once post-trial after menstruation

Countries

India

Contacts

Public ContactHina Meraj

Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh

abihaahmad89@gmail.com9620551870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026